Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Retrovirus Life Cycles

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...

Sexually Transmitted Infections

Sexually Transmitted Infections

Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...

Retroviruses

Retroviruses

Retroviruses and retrotransposons both insert copies of their genetic elements into the genome of the host cell. Thus, the viral genes are passed on when the host genome is replicated or translated. A typical retroviral DNA sequence contains 3-4 genes that encode the different proteins required for its structural assembly and function as a molecular parasite. This DNA is transcribed into a single mRNA, which is very similar in structure to conventional mRNAs, i.e., it is capped at the 5’...

Viral Hepatitis I: Introduction

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Sp1 links CD46 to CD4 T cell metabolic fitness, survival, and retroviral control.

Science immunology·2026

Same author

Safety, immunovirological, and CNS effects of PD-1 inhibition in people with HIV without malignancy.

The Journal of infectious diseases·2026

Same author

The Dp16 Down syndrome mouse model does not exhibit oral interferon-gammopathy or susceptibility to oral candidiasis.

mBio·2026

Same author

Cross-neutralizing and potent human monoclonal antibodies against historical and emerging H5Nx influenza viruses.

Nature microbiology·2025

Same author

Single cell technologies and the biology of HIV-infected CD4 T-cell reservoirs.

Current opinion in HIV and AIDS·2025

Same author

The Immunophenotype and Proviral Landscape of HIV-infected CD4 T Cells During Antiretroviral Therapy.

bioRxiv : the preprint server for biology·2025

Search research articles

Related Experiment Video

Updated: May 14, 2026

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice

Published on: October 6, 2022

ART Interrupted: Insights into ART-free HIV remission.

Ramon A Lujan¹, Eli A Boritz¹

¹Virus Persistence and Dynamics Section, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.

|May 12, 2026

Summary

This summary is machine-generated.

Understanding HIV rebound is key to finding a cure. This study links specific immune cells and genes like DDIT4 to delayed viral rebound, with metformin showing potential for HIV silencing.

More Related Videos

Methods Development for Blood Borne Macrophage Carriage of Nanoformulated Antiretroviral Drugs

Methods Development for Blood Borne Macrophage Carriage of Nanoformulated Antiretroviral Drugs

Published on: December 9, 2010

Related Experiment Videos

Last Updated: May 14, 2026

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice

Published on: October 6, 2022

Methods Development for Blood Borne Macrophage Carriage of Nanoformulated Antiretroviral Drugs

Methods Development for Blood Borne Macrophage Carriage of Nanoformulated Antiretroviral Drugs

Published on: December 9, 2010

Area of Science:

* Immunology
* Virology
* Genetics

Background:

* Antiretroviral therapy (ART) controls HIV but does not eliminate the virus.
* Understanding HIV rebound dynamics after ART interruption is crucial for developing a functional cure.
* Identifying host factors that control viral persistence is a key research area.

Purpose of the Study:

* To identify host immune and genetic factors associated with delayed HIV rebound after ART cessation.
* To explore the role of specific genes, DDIT4 and ZNF254, as potential HIV silencing factors.
* To investigate the effect of metformin on HIV replication in vitro.

Main Methods:

* Analysis of immunophenotypes and transcriptomes from participants in multiple clinical trials.
* Correlation analysis between immune cell subsets and time to HIV rebound.
* In vitro experiments assessing the impact of metformin on HIV silencing.

Main Results:

* Specific T and Natural Killer (NK) cell subsets were associated with delayed HIV rebound.
* DDIT4 and ZNF254 were identified as host factors contributing to HIV silencing.
* The antidiabetic drug metformin demonstrated the ability to induce DDIT4 and silence HIV replication in vitro.

Conclusions:

* Host immune cell profiles and specific gene expression (DDIT4, ZNF254) are linked to HIV rebound kinetics.
* DDIT4 and ZNF254 represent potential targets for HIV cure strategies.
* Metformin shows promise as an agent for inducing HIV silencing through DDIT4 induction.